JAK inhibitors: special issue foreword

James Galloway; Fabiola Atzeni

doi:10.1080/1744666X.2022.2050596

JAK inhibitors: special issue foreword

James Galloway^*, Fabiola Atzeni

^*Corresponding author for this work

Inflammation Biology

Research output: Contribution to journal › Editorial › peer-review

1 Citation (Scopus)

Original language	English
Pages (from-to)	179-180
Number of pages	2
Journal	Expert Review Of Clinical Immunology
Volume	18
Issue number	3
DOIs	https://doi.org/10.1080/1744666X.2022.2050596
Publication status	Published - 2022

Keywords

autoimmune disease
cardiovascular risk
JAKi
thromboembolism
tsDMARDs

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1080/1744666X.2022.2050596

Cite this

@article{4c1fa0a00edf4a2991a0dd1030293f7c,

title = "JAK inhibitors: special issue foreword",

keywords = "autoimmune disease, cardiovascular risk, JAKi, thromboembolism, tsDMARDs",

author = "James Galloway and Fabiola Atzeni",

year = "2022",

doi = "10.1080/1744666X.2022.2050596",

language = "English",

volume = "18",

pages = "179--180",

journal = "Expert Review Of Clinical Immunology",

issn = "1744-666X",

publisher = "Taylor and Francis Ltd.",

number = "3",

}

TY - JOUR

T1 - JAK inhibitors

T2 - special issue foreword

AU - Galloway, James

AU - Atzeni, Fabiola

PY - 2022

Y1 - 2022

KW - autoimmune disease

KW - cardiovascular risk

KW - JAKi

KW - thromboembolism

KW - tsDMARDs

UR - http://www.scopus.com/inward/record.url?scp=85126473638&partnerID=8YFLogxK

U2 - 10.1080/1744666X.2022.2050596

DO - 10.1080/1744666X.2022.2050596

M3 - Editorial

C2 - 35254191

AN - SCOPUS:85126473638

SN - 1744-666X

VL - 18

SP - 179

EP - 180

JO - Expert Review Of Clinical Immunology

JF - Expert Review Of Clinical Immunology

IS - 3

ER -

JAK inhibitors: special issue foreword

Keywords

UN SDGs

Access to Document

Other files and links

Cite this